Breaks Categories: Stock Spotlights

ThursdayMar 22, 2018 12:34 pm

CannabisNewsBreaks – Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) Leverages Opportunity in Cannabis Industry through Strategic, Diversified Investments

Liberty Leaf Holdings (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) offers investors a unique option for diversified exposure across the entire legal cannabis market. An article discussing the company reads: “Liberty Leaf takes calculated and strategic investment positions in established, proven performers in both the medicinal and recreational legal cannabis markets. Liberty Leaf targets and then acquires and/or partners with established, revenue-producing marijuana businesses that have large upside potential. Liberty’s objective is to build a substantial, broad-based portfolio of multiple cannabis-sector businesses, including companies across the full spectrum of activities, from the cultivation and processing of legal medicinal and recreational cannabis…

Continue Reading

FridayMar 16, 2018 12:36 pm

CannabisNewsBreaks – Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Plans to Progress in Industrial Hemp Sector through Strategic Partnerships, Acquisitions

Hemp cultivation company Global Hemp Group (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is on a mission to capture cash flow, generate revenues and create value for its shareholders through the execution of joint ventures, partnerships, and acquisitions. An article discussing the company reads: “Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is focused on the vital role that industrial hemp will play in building a sustainable future. The company concentrates on the production and processing of hemp to produce raw and finished goods for domestic and international markets. … Through a series of partnerships, joint ventures and acquisitions,…

Continue Reading

WednesdayMar 14, 2018 11:44 am

CannabisNewsBreaks – Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) and Blox Labs, Inc. (CSE: BLOX) (OTC: BLLXF) Complete Preliminary Input and Analysis in Phase One Development of cannaBLOX

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) is working in partnership with Blox Labs, Inc. (CSE: BLOX) (OTC: BLLXF) to create cannaBLOX, a blockchain-based software smart contract platform for the legalized cannabis industry. An article discussing the joint development reads: “Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) and Blox Labs, Inc. (CSE: BLOX) (OTC: BLLXF) have announced progress on their joint development of phase one of cannaBLOX, the blockchain-based smart contract platform for the legalized cannabis industry (http://cnw.fm/4DmPU). … Blox Labs is working to complete its white paper on cannaBLOX, and a satellite development…

Continue Reading

FridayMar 09, 2018 3:11 pm

CannabisNewsBreaks – Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) Grows in Cannabis Industry through Strategic Investments

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) is a vertically-integrated cannabis company with strategic investments focusing on proven, revenue-generating businesses. An article discussing the company reads: “Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) is a publicly traded Canadian-based company with strategic investments in businesses that are established, revenue- producing players in the medicinal and recreational cannabis market. Liberty Leaf’s focus is to build and support a diversified portfolio of cannabis-sector businesses, including those involved in the cultivation and processing of legal medicinal and recreational cannabis, value-added CBD/THC pet products, and supply-chain products for this…

Continue Reading

FridayMar 09, 2018 3:05 pm

CannabisNewsBreaks – PreveCeutical Medical Inc.’s (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Proprietary Sol-gel Formulations May Significantly Improve Bioavailability

Health sciences company PreveCeutical Medical (PRVCF) is engineering a unique Sol-gel CBD-based technology delivery platform to provide direct, controlled pharmacological drug release. This technology could provide a clinical benefit for patients seeking relief for multiple medical indications including pain, inflammation, seizures and neurological disorders. An article discussing the company’s proprietary technology reads: “PreveCeutical’s proprietary Sol-gel formulations begin as a liquid that is administrated into the nose, which then forms a gel as it is warmed in the nasal cavity where it can then be absorbed. This effectively bypasses the stomach and intestines – eliminating first pass metabolism – and may…

Continue Reading

ThursdayMar 08, 2018 3:42 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Innovative Technology is Well-suited in the Cannabis Industry

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) has recently developed an oral digestion technology, DehydraTECH™, which is a complementary layer that works with other R&D efforts regarding cannaboids. An article discussing the company reads: “DehydraTECH allows for faster delivery time, lower dosages and shorter treatment regimens. Oral ingestion of the client drug eliminates unhealthy practices of inhalation dosing. It improves the absorption rate, by as much as five to 10 times, of non-steroid anti-inflammatory drugs (NSAIDs), vitamins, cannabinoids and even nicotine. Delivery time, the time it takes from ingestion to payload molecules reaching the bloodstream, is reduced from the 60-90 minutes…

Continue Reading

TuesdayMar 06, 2018 3:19 pm

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. Continues Large Scale Cannabis Production as Supply Deficit Approaches

Ultra-low cost organic cannabis producer The Green Organic Dutchman Holdings Ltd., also known as TGOD, is set to reap the benefits from an impending shortage of cannabis in Canada. An article discussing the company reads: “As one of just two producers of organic cannabis and with a million square feet of low cost production planned, the Green Organic Dutchman Holdings Ltd. (“TGOD”) is set to capitalize on Canada’s looming supply shortfall. The company is growing its competitive advantage in a way that appears to run contrary to established dictum by focusing not just on differentiation but also on cost leadership.…

Continue Reading

FridayMar 02, 2018 3:32 pm

CannabisNewsBreaks – Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) Pursues its Share of America’s Prosperous Cannabis Industry

Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is employing a “Soil-to-Shelf” strategy for development of hemp in Canada and the United States. An article discussing the company reads: “Global Hemp plans to apply for a license to extract cannabidiol (CBD) and other cannabinoids from the upcoming industrial hemp crop in New Brunswick. Discussions are also underway with potential processing partners for the extraction of cannabinoids and straw processing for building materials from this harvest in the fall of 2018, with a longer-term plan to establish permanent processing facilities by the end of 2019. Global Hemp also continues…

Continue Reading

FridayMar 02, 2018 12:53 pm

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. Thrives in Canadian Cannabis Industry

Ultra-low cost organic cannabis producer The Green Organic Dutchman Holdings Ltd., also known as TGOD, is on track to become one of the world’s largest, most technically advanced cannabis producers. An article discussing the company reads: “Headquartered in Hamilton, Ontario, The Green Organic Dutchman Holdings Ltd., known as “TGOD”, has formed strategic alliances with industry leaders with a view to becoming the world’s largest organic cannabis company. To achieve this goal, the company has taken an approach unique in the cannabis industry, by growing cannabis organically at a low cost, expanding its cultivation facilities to scale, hiring world class senior…

Continue Reading

ThursdayFeb 22, 2018 2:55 pm

CannabisNewsBreaks – Teewinot Life Sciences Produces Cannabinoids through Patent-protected CANNSYNTHESIS Technology

Cannabinoid-based pharmaceuticals company Teewinot Life Sciencess employs its patent-protected CANNSYNTHESIS® technology to biosynthesize cannabinoids for the large-scale manufacture of pharmaceutically pure cannabinoids. An article discussing the company’s technology reads: “Apart from THC and CBD, many of the 111 or so cannabinoids found in the cannabis plant are produced in minute quantities. Production by extraction is thus prohibitively costly, meaning that most cannabinoids have not been available for research and therapeutic applications. The CANNSYNTHESIS® platform has changed that paradigm, however, since it allows for the efficient production of cannabinoids in kilogram quantities. Teewinot’s CANNSYNTHESIS® has taken the production of cannabinoids from…

Continue Reading